The first high-oxidation-state, molybdenum complexes with a pentaarylcyclopentadienyl ligand have been prepared. Oxidation of [Mo(C5Ph4R)(CO)3Br] (R = 2,5-dimethoxyphenyl) with dioxygen in boiling toluene provides a high yield route to the 16-electron, molybdenum(VI) complex [Mo(C5Ph4R)O2Br]. Reactions of this complex with aliphatic alcohols (R″OH), but not with phenols, afforded the alkoxide complexes [Mo(C5Ph4R)O2(OR″)]. The complexes are unstable to hydrolysis; the cyclopentadiene C5Ph4RH is isolated from reactions with water. Crystal structure analyses of the cyclopentadiene C5Ph4RH and of [Mo(C5Ph4R)O2(OMe)] were made. The orientation of the dimethoxyphenyl substituent, with the o-methoxy group directed either towards or away from the metal centre, leads to proximal and distal rotamers for each complex. The proximal rotamer of [Mo(C5Ph4R)O2(OMe)] crystallises. The NMR spectra of the complexes show peaks for the proximal and distal rotamers. A variable-temperature 1H NMR study of [Mo(C5Ph4R)O2Br] allowed calculation of the rotational barrier for the dimethoxyphenyl substituent: ΔG‡ = 68.6 ± 0.8 kJ mol–1. A MoVI–MoV couple is observed for [Mo(C5Ph4R)O2Br] at –0.55 V (vs. the ferrocene–ferrocenium couple), and the corresponding couples for the alkoxide complexes occur at ca. –1.55 V.
No takes yet. Share an insight, caveat, or question.
Harrison et al. (1997) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: